Medtronic Plc (MDT)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Omar S. Ishrak
Employees:
86,000
20 ON HATCH, LOWER HATCH STREET, DUBLIN, IRELAND 2
01135314381700

Medtronic Plc is engaged in the medical technology-alleviating pain, restoring health, and extending life for millions of people around the world. Its customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. The company operates through four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group consist of three divisions : Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group consists of two divisions: Surgical Solutions and Patient Monitoring and Recovery. The Restorative Therapies Group consists of four divisions: Spine, Neuromodulation, Surgical Technologies and Neurovascular. The Diabetes Group consists of three divisions: Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. The company was founded on January 26, 2015 and is headquartered in Dublin, Ireland.

Data derived from most recent annual or quarterly report
Market Cap 143.623 Billion Shares Outstanding1.344 Billion Avg 30-day Volume 6.449 Million
P/E Ratio48.9122 Dividend Yield1.781 EPS0.97
Price to Revenue5.8564 Debt to Equity0.5114 EBITDA7.522 Billion
Price to Book Value3.4296 Operating Margin14.888599999999999 Enterprise Value192.123 Billion
Current Ratio2.65 EPS Growth-0.249 Quick Ratio1.913
1 Yr BETA 0.8749 52-week High/Low 135.23 / 105.02 Profit Margin12.053
Operating Cash Flow Growth-13.7407 Altman Z-Score3.6567 Free Cash Flow to Firm 0
View SEC Filings from MDT instead.

View recent insider trading info

Funds Holding MDT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MDT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KUNTZ RICHARD SVP & CHIEF MEDICAL & SCIENCE

  • Officer
74,945 2021-11-05 2

WALL BRETT A. EVP & PRES NEUROSCIENCE

  • Officer
25,251 2021-11-05 4

LERMAN BRADLEY E SVP GENERAL COUNSEL & CORP SEC

  • Officer
48,635 2021-11-05 5

WHITE ROBERT JOHN EVP & PRES. MEDICAL SURGICAL

  • Officer
48,148 2021-11-05 3

LIDDICOAT JOHN R EVP & PRESIDENT OF AMERICAS

  • Officer
42,998 2021-11-05 3

SALMON SEAN EVP & PRES DIABETES/CARDIOVASC

  • Officer
33,172 2021-11-05 4

TEN HOEDT ROB EVP & PRESIDENT EMEA

  • Officer
54,168 2021-11-01 3

PARKHILL KAREN L EVP & CHIEF FINANCIAL OFFICER

  • Officer
85,833 2021-10-06 6

MARTHA GEOFFREY CEO

  • Officer
  • Director
113,355 2021-08-25 4

SURFACE CAROL A SVP, CHIEF HR OFFICER

  • Officer
76,367 2021-08-02 2

KIRK JENNIFER M CHIEF ACCOUNTING OFFICER

  • Officer
22,093 2021-08-02 2

OLEARY DENISE M

  • Director
68,745 2021-05-03 2

ARNOLD CRAIG

  • Director
32,954 2021-05-03 2

LENEHAN JAMES T

  • Director
57,849 2021-05-03 2

HOGAN RANDALL J

  • Director
39,766 2021-05-03 2

ANDERSON RICHARD H

  • Director
110,330 2021-05-03 2

DONNELLY SCOTT C

  • Director
13,594 2021-05-03 2

POWELL KENDALL J

  • Director
38,466 2021-05-03 2

LOFTON KEVIN E

  • Director
820 2021-05-03 1

LEAVITT MICHAEL O

  • Director
21,779 2021-05-03 1

NABEL ELIZABETH G

  • Director
10,353 2021-05-03 2

GOLDSMITH ANDREA JO

  • Director
2,985 2021-05-03 2

COYLE MICHAEL J EVP & GROUP PRES, CARDIAC&VASC

  • Officer
194,744 2020-11-03 0

ISHRAK OMAR EXECUTIVE CHAIRMAN

  • Officer
  • Director
609,672 2020-10-15 0

HAKAMI HOOMAN EVP & GROUP PRESIDENT DIABETES

  • Officer
30,761 2019-09-10 0

POZEN ROBERT C

  • Director
60,964 2018-08-23 0

JACKSON SHIRLEY A

  • Director
38,525 2018-04-30 0

HANSON BRYAN C EVP, PRESIDENT, MITG

  • Officer
88,818 2017-12-15 0

ELLIS GARY LEE EVP & GLOBAL OPS AND IT

  • Officer
No longer subject to file 2016-12-30 0

REDDY PREETHA

  • Director
7,823 2016-05-02 0

OCONNELL CHRISTOPHER J EVP & GROUPPRES RESTORA THERAP

95,928 2015-02-18 0

DZAU VICTOR J

18,610 2014-06-30 0

SZYMAN CATHERINE M SRVP & PRES DIABETES

21,602 2014-04-17 0

AYOTTE NEIL P VP INTERIM GEN COUNSEL CORPSEC

12,579 2014-03-10 0

DALLAS H JAMES SRVP QUALITY, OPERATIONS, IT

59,141 2013-08-22 0

FINDLAY D CAMERON SRVP GNERAL COUNSEL & CORP SEC

80,977 2013-06-26 0

SCHULER JACK W

678,888 2013-04-29 0

STOCKDALE CAROLINE SR VP HUMAN RESOURCES

44,221 2012-10-29 0

ROSSO JEAN PIERRE

30,654 2012-04-30 0

CALHOUN DAVID L

23,612 2012-04-30 0

BUTEL JEAN LUC EVP & GROUP PRES MDT INTL

130,959 2012-01-11 0

HAWKINS WILLIAM A CHAIRMAN & CEO

435,536 2011-06-01 0

MACKIN JAMES P SVP & PRES CRDM

97,790 2010-10-29 0

WARD SCOTT R SVP & PRES CARDIOVASCULAR

112,514 2010-04-30 0

LANEVE STEPHEN SVP & PRES SPINAL & BIOLOGICS

42,271 2010-04-09 0

ARONSON MARTHA GOLDBERG SRVP CHIEF TALENT OFFICER

84,263 2009-10-30 0

OESTERLE STEPHEN N SRVP MEDICINE & TECHNOLOGY

53,480 2009-08-03 0

ALPERT SUSAN PHD MD SRVP CHIEF REGULATORY

30,336 2009-08-03 0

BLANKEMEYER ROBERT H SVP & PRES SURGICAL TECHNOL

34,952 2009-08-03 0

MAHLE STEPHEN H EXECVP HEALTHCARE POLICY & REG

323,660 2008-10-27 0

CARLSON TERRANCE L SRVP GNERAL COUNSEL & CORP SEC

74,269 2008-10-27 0

COLLINS ARTHUR D JR RETIRED CHAIRMAN OF THE BOARD

  • Director
No longer subject to file 2008-08-21 0

STUGE OERN SVP & PRES EUROPE CENTRAL ASIA

  • Officer
59,530 2008-06-13 0

DEMANE MICHAEL F CHIEF OPERATING OFFICER

  • Officer
144,286 2008-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SALMON SEAN - Officer EVP & PRES DIABETES/CARDIOVASC

2021-11-09 18:05:19 -0500 2021-11-05 F 245 $122.98 d 33,172 direct -2.3119 -3.7415 0.0 1 -3.9458 4

LIDDICOAT JOHN R - Officer EVP & PRESIDENT OF AMERICAS

2021-11-09 18:03:35 -0500 2021-11-05 F 139 $122.98 d 42,998 direct -2.3119 -3.7415 0.0 1 -3.9458 4

WALL BRETT A. - Officer EVP & PRES NEUROSCIENCE

2021-11-09 18:06:55 -0500 2021-11-05 F 238 $122.98 d 25,251 direct -2.3119 -3.7415 0.0 1 -3.9458 4

KUNTZ RICHARD - Officer SVP & CHIEF MEDICAL & SCIENCE

2021-11-09 17:58:19 -0500 2021-11-05 F 209 $122.98 d 74,945 direct -2.3119 -3.7415 0.0 1 -3.9458 4

WHITE ROBERT JOHN - Officer EVP & PRES. MEDICAL SURGICAL

2021-11-09 18:08:50 -0500 2021-11-05 F 246 $122.98 d 46,648 direct -2.3119 -3.7415 0.0 1 -3.9458 4

LERMAN BRADLEY E - Officer SVP GENERAL COUNSEL & CORP SEC

2021-11-09 18:01:45 -0500 2021-11-05 F 250 $122.98 d 48,635 direct -2.3119 -3.7415 0.0 1 -3.9458 4

TEN HOEDT ROB - Officer EVP & PRESIDENT EMEA

2021-11-03 17:50:03 -0400 2021-11-01 A 6,670 a 6,670 direct

TEN HOEDT ROB - Officer EVP & PRESIDENT EMEA

2021-11-03 17:50:03 -0400 2021-11-01 A 832 a 45,418 direct 1.8974 -0.9197 1.9306 3 -0.9197 6

TEN HOEDT ROB - Officer EVP & PRESIDENT EMEA

2021-11-03 17:50:03 -0400 2021-11-01 A 2,080 a 2,080 direct

PARKHILL KAREN L - Officer EVP & CHIEF FINANCIAL OFFICER

2021-10-14 17:41:05 -0400 2021-10-08 G 12,000 d 35,974 direct -5.5029 -3.6477 -13.6751 0.0 1 -13.6751 31

PARKHILL KAREN L - Officer EVP & CHIEF FINANCIAL OFFICER parkhill family trust

2021-10-14 17:41:05 -0400 2021-10-08 G 12,000 a 49,859 indirect -5.5029 -3.6477 -13.6751 0.0 1 -13.6751 31

PARKHILL KAREN L - Officer EVP & CHIEF FINANCIAL OFFICER

2021-10-14 17:41:05 -0400 2021-10-06 G 37,859 d 47,974 direct -5.5029 -3.6477 -13.6751 0.0 1 -13.6751 31

PARKHILL KAREN L - Officer EVP & CHIEF FINANCIAL OFFICER parkhill family trust

2021-10-14 17:41:05 -0400 2021-10-06 G 37,859 a 37,859 indirect -5.5029 -3.6477 -13.6751 0.0 1 -13.6751 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MEDTRONIC PLC MDT 2021-12-03 22:15:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 21:45:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 21:15:04 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 20:45:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 20:15:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 19:45:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 19:15:04 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 18:45:04 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 18:15:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 17:45:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 17:15:03 UTC -0.3147 0.3847 0
MEDTRONIC PLC MDT 2021-12-03 16:45:03 UTC -0.3057 0.3757 0
MEDTRONIC PLC MDT 2021-12-03 16:15:04 UTC -0.3057 0.3757 0
MEDTRONIC PLC MDT 2021-12-03 15:45:03 UTC -0.3057 0.3757 0
MEDTRONIC PLC MDT 2021-12-03 15:15:03 UTC -0.3057 0.3757 0
MEDTRONIC PLC MDT 2021-12-03 14:45:03 UTC -0.2948 0.3648 0
MEDTRONIC PLC MDT 2021-12-03 14:15:05 UTC -0.2948 0.3648 0
MEDTRONIC PLC MDT 2021-12-03 13:45:03 UTC -0.2948 0.3648 0
MEDTRONIC PLC MDT 2021-12-03 13:15:03 UTC -0.2948 0.3648 0
MEDTRONIC PLC MDT 2021-12-03 12:45:03 UTC -0.2948 0.3648 0

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Master Neutral Fund MDT -10.0 shares, $-1039.2 2020-09-30 N-PORT
M3Sixty Funds Trust- AXS Market Neutral Fund MDT -820.0 shares, $-96054.8 2020-12-31 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund MDT -390.0 shares, $-51210.9 2021-07-31 N-PORT
Weiss Strategic Interval Fund- Weiss Strategic Interval Fund MDT -6878.0 shares, $-862157.3 2021-09-30 N-PORT
Federated Hermes Equity Funds- Federated Hermes Prudent Bear Fund MDT -1000.0 shares, $-125350.0 2021-09-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST II- AXS Market Neutral Fund MDT -456.0 shares, $-57159.6 2021-09-30 N-PORT

Elevate your investments